» Articles » PMID: 15579747

Long-term Follow-up of Thyroid Function in Patients Who Received Bone Marrow Transplantation During Childhood and Adolescence

Abstract

An increasing number of long-term surviving bone marrow transplant (BMT) recipients have recovered from their primary disease but are at risk of developing failure of endocrine organs. We investigated 147 patients who underwent allogeneic BMT. Thyroid function was evaluated by serial measurement of basal TSH and free T4 levels as well as by TRH provocative test. Thyroid ultrasound examination was performed for evaluation of thyroid tumor after BMT. Five patients were found to have overt thyroid dysfunction (hypothyroidism in four patients and hyperthyroidism in one patient). Twenty-three patients in the under 9-yr-old group at BMT and 16 patients in the over 10-yr-old group at BMT had subclinical compensated hypothyroidism. Younger age at BMT was the strongest factor for developing thyroid dysfunction, compared with older age (P < 0.001). Only in patients with subclinical compensated hypothyroidism did median basal and peak TSH increase to the upper half of the normal range by 8 yr after BMT and then returned slightly to the middle of the normal range spontaneously. These results suggest that thyroid dysfunction in long-term BMT survivors depends on age at BMT, with a greater risk among younger patients, indicating the need for life-long surveillance.

Citing Articles

Thyroid complications after hemopoietic stem cell transplantation in children and adolescents.

Fotiadou A, Paisiou A, Goussetis E, Kafetzi M, Karayanni V, Peristeri I Hormones (Athens). 2024; 23(4):699-707.

PMID: 39004683 DOI: 10.1007/s42000-024-00584-5.


Long-term toxicities after allogeneic hematopoietic stem cell transplantation with or without total body irradiation: a population-based study in Korea.

Kwon J, Kim B Radiat Oncol J. 2024; 42(1):50-62.

PMID: 38549384 PMC: 10982063. DOI: 10.3857/roj.2023.00871.


[Chinese expert consensus on the management of long-term complications after hematopoietic stem cell transplantation (2023)].

Zhonghua Xue Ye Xue Za Zhi. 2023; 44(9):717-722.

PMID: 38049314 PMC: 10630577. DOI: 10.3760/cma.j.issn.0253-2727.2023.09.003.


Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: State of the art and practical recommendations for a risk-based follow-up.

Cattoni A, Molinari S, Riva B, Di Marco S, Adavastro M, Faraguna M Front Endocrinol (Lausanne). 2023; 13:1064146.

PMID: 36619560 PMC: 9811586. DOI: 10.3389/fendo.2022.1064146.


To Lighten the Burden of Cure: Thyroid Disease in Long-Term Survivors After TBI Conditioning for Paediatric ALL.

Zubarovskaya N, Bauer D, Ronceray L, Poetschger U, Kurzmann P, Lender C Front Pediatr. 2022; 9:798974.

PMID: 35127596 PMC: 8809136. DOI: 10.3389/fped.2021.798974.